SA PRO
Free Account
Incyte CorporationINCYNASDAQ
LOADING
|||
OverviewNewsFundamentalsEarningsAnalysts

Analyst Sentiment

Analysts are neutral — opinion is divided on direction.

Consensus Rating
Hold
26 analysts·High coverage
54%
Rating Distribution
Strong Buy
00%
Buy
1454%
Hold
1038%
Sell
28%
Strong Sell
00%

Analyst ratings reflect Wall Street opinion, not guarantees. Historical accuracy varies by firm and sector.

Price Target Expectations

Current price is 5% above analyst consensus — near fair value expected.

Bear Case
$68.00
-36%
Consensus
$101.00
-5%
Bull Case
$121.00
+14%
Price Range26 analysts
Low
Consensus
High
$68.00
$121.00
Current Target
Current Price
$105.95
Above Target
$4.95

Price targets are 12-month forecasts. Actual results depend on earnings, market conditions, and sector trends.

Earnings & Revenue Estimates

Earnings Surprises

Beat rate:50%(6/12 quarters)
Avg surprise:-28.9%
Beat
Miss
Inline
Estimate
Based on reported EPS vs consensus estimate.

Recent Analyst Actions

Jan 8, 2026Goldman Sachs
Incyte price target raised to $90 from $80 at Goldman Sachs
Target:$90.00
-18.6%from $110.57
Jan 5, 2026Stifel Nicolaus
Stifel Reiterates Buy Rating on Incyte (INCY)
Target:$119.00
+16.9%from $101.79
Dec 24, 2025Truist Financial
Incyte price target raised to $103 from $93 at Truist
Target:$103.00
+2.1%from $100.91
Dec 8, 2025Morgan Stanley
Incyte price target raised to $92 from $86 at Morgan Stanley
Target:$92.00
-4.6%from $96.47
Dec 8, 2025Wells Fargo
Incyte price target raised to $116 from $97 at Wells Fargo
Target:$116.00
+13.1%from $102.52
Dec 8, 2025Mizuho Securities
Incyte upgraded to Outperform from Neutral at Mizuho
Target:$121.00
+18.0%from $102.52
Nov 24, 2025Barclays
Incyte price target raised to $115 from $101 at Barclays
Target:$115.00
+12.7%from $102.06
Nov 4, 2025Piper Sandler
Incyte price target raised to $102 from $82 at Piper Sandler
Target:$102.00
-0.3%from $102.35
Oct 29, 2025Truist Financial
Incyte price target raised to $93 from $79 at Truist
Target:$93.00
+2.9%from $90.35
Oct 29, 2025RBC Capital
Incyte price target raised to $84 from $81 at RBC Capital
Target:$84.00
-8.3%from $91.65
Oct 29, 2025Wells Fargo
Incyte price target raised to $97 from $89 at Wells Fargo
Target:$97.00
+5.4%from $92.02
Oct 29, 2025Barclays
Incyte price target raised to $101 from $90 at Barclays
Target:$101.00
+10.2%from $91.65
Jul 30, 2025UBS
Incyte price target raised to $68 from $62 at UBS
Target:$68.00
-12.3%from $77.55
Jun 23, 2025RBC Capital
J&J's '968 delay has mixed readthroughs for Incyte's '989, says RBC
Target:$67.00
-0.4%from $67.26
Mar 18, 2025Guggenheim
Guggenheim downgrades Incyte on povorcitinib's 'somewhat underwhelming' profile
Target:$92.00
+53.3%from $60.00
Oct 30, 2024Seaport Global
This Alphabet Analyst Turns Bullish; Here Are Top 5 Downgrades For Wednesday
Target:$200.00
+174.0%from $73.00
Oct 30, 2024Oppenheimer
Incyte price target raised to $82 from $81 at Oppenheimer
Target:$82.00
+11.4%from $73.60
Oct 30, 2024Citigroup
Incyte (INCY) PT Raised to $97 at Citi
Target:$97.00
+31.8%from $73.60
Oct 29, 2024Jefferies
Incyte (INCY) PT Raised to $84 at Jefferies
Target:$84.00
+14.1%from $73.60
Oct 29, 2024Bank of America Securities
BofA Securities Upgrades Incyte (INCY) to Buy
Target:$90.00
+22.3%from $73.60
Sep 30, 2024Wolfe Research
Wolfe Research starts Incyte at Outperform amid 'major push' in I&I
Target:$84.00
+27.1%from $66.10
Sep 16, 2024Bank of America Securities
Incyte (INCY) PT Raised to $68 at BofA Securities
Target:$68.00
+7.0%from $63.56
Sep 16, 2024Goldman Sachs
Goldman Sachs Reiterates Neutral Rating on Incyte (INCY)
Target:$60.00
-5.6%from $63.56
Aug 18, 2024Citigroup
Incyte price target raised to $92 from $88 at Citi
Target:$92.00
+48.0%from $62.16
Jul 31, 2024RBC Capital
Incyte price target raised to $66 from $61 at RBC Capital
Target:$66.00
+0.5%from $65.70

Explore More

S&P 500 Screener

Filter and sort all 500 stocks

Market Movers

Today's biggest gainers and losers

Market Heatmap

Visual sector performance